0000899243-19-006209.txt : 20190305 0000899243-19-006209.hdr.sgml : 20190305 20190305181541 ACCESSION NUMBER: 0000899243-19-006209 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190301 FILED AS OF DATE: 20190305 DATE AS OF CHANGE: 20190305 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Campbell Paul CENTRAL INDEX KEY: 0001657568 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 333-199861 FILM NUMBER: 19660224 MAIL ADDRESS: STREET 1: BUILDING 4, TRIDENT PLACE STREET 2: MOSQUITO WAY CITY: HATFIELD, HERTFORDSHIRE STATE: X0 ZIP: AL10 9UL ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Mylan N.V. CENTRAL INDEX KEY: 0001623613 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 981189497 STATE OF INCORPORATION: P7 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: BUILDING 4, TRIDENT PLACE, MOSQUITO WAY CITY: HATFIELD, HERTFORDSHIRE STATE: X0 ZIP: AL10 9UL BUSINESS PHONE: 44 0 1707 853 000 MAIL ADDRESS: STREET 1: BUILDING 4, TRIDENT PLACE, MOSQUITO WAY CITY: HATFIELD, HERTFORDSHIRE STATE: X0 ZIP: AL10 9UL FORMER COMPANY: FORMER CONFORMED NAME: New Moon B.V. DATE OF NAME CHANGE: 20141028 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2019-03-01 0 0001623613 Mylan N.V. MYL 0001657568 Campbell Paul BUILDING 4, TRIDENT PLACE, MOSQUITO WAY HATFIELD, HERTFORDSHIRE X0 AL10 9UL UNITED KINGDOM 0 1 0 0 See Remarks Ordinary Shares 2019-03-02 4 M 0 1980 0.00 A 24540 D Ordinary Shares 2019-03-02 4 F 0 877 27.45 D 23663 D Ordinary Shares 2019-03-02 4 M 0 167 0.00 A 437 I By Spouse Ordinary Shares 2019-03-02 4 F 0 57 27.45 D 380 I By Spouse Ordinary Shares 2019-03-03 4 M 0 830 0.00 A 24493 D Ordinary Shares 2019-03-03 4 F 0 356 27.45 D 24137 D Ordinary Shares 2019-03-03 4 M 0 219 0.00 A 599 I By Spouse Ordinary Shares 2019-03-03 4 F 0 75 27.45 D 524 I By Spouse Ordinary Shares (pursuant to existing trading plan) 2019-03-04 4 X 0 11533 12.15 A 35670 D Ordinary Shares (pursuant to existing trading plan) 2019-03-04 4 S 0 11533 27.4987 D 24137 D Ordinary Shares 2019-03-05 5 G 0 E 524 0.00 D 0 I By Spouse Ordinary Shares 2019-03-05 5 G 0 E 524 0.00 A 24661 D Ordinary Shares 318 I By 401(k) Plan Employee Stock Option - Right to Buy 27.45 2019-03-01 4 A 0 7398 0.00 A 2029-03-01 Ordinary Shares 7398 7398 D Employee Stock Option - Right to Buy 27.45 2019-03-01 4 A 0 460 0.00 A 2029-03-01 Ordinary Shares 460 460 I By Spouse Restricted Stock Units 0.00 2019-03-01 4 A 0 12387 0.00 A Ordinary Shares 12387 12387 D Restricted Stock Units 0.00 2019-03-01 4 A 0 1154 0.00 A Ordinary Shares 1154 1154 I By Spouse Restricted Stock Units 0.00 2019-03-02 4 M 0 1980 0.00 D Ordinary Shares 1980 3960 D Restricted Stock Units 0.00 2019-03-02 4 M 0 167 0.00 D Ordinary Shares 167 334 I By Spouse Restricted Stock Units 0.00 2019-03-03 4 M 0 830 0.00 D Ordinary Shares 830 830 D Restricted Stock Units 0.00 2019-03-03 4 M 0 219 0.00 D Ordinary Shares 219 220 I By Spouse Employee Stock Option - Right to Buy 12.15 2019-03-04 4 X 0 11533 0.00 D Ordinary Shares 11533 0 D Represents withholding of ordinary shares for the tax liability associated with the vesting and settlement of a portion of the restricted stock units (RSUs) granted on March 2, 2018. Represents withholding of ordinary shares for the tax liability associated with the vesting and settlement of a portion of the RSUs granted on March 3, 2017. The exercise of stock options and sale of ordinary shares were executed pursuant to a 10b5-1 trading plan executed on March 5, 2018. Represents the acquisition of Mylan ordinary shares upon exercise of stock options granted on March 5, 2009. Represents the weighted average price of the reporting person's disposition of 11,533 ordinary shares in transactions ranging from $27.37 to $27.59. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of ordinary shares sold at each separate price within the range set forth in this footnote. This transaction involved a gift of securities by the reporting person's spouse to the reporting person on March 5, 2019. These options vest in three equal annual installments beginning on March 2, 2020 and expire on March 1, 2029. 154 of the options will vest on March 2, 2020, and 153 will vest on each of March 2, 2021 and March 2, 2022. The options expire on March 1, 2029. Each RSU represents the right to receive one ordinary share of Mylan N.V. The RSUs vest in three equal annual installments beginning on March 2, 2020. Each RSU represents the right to receive one ordinary share of Mylan N.V. 385 of the RSUs will vest on March 2, 2020, 384 will vest on March 2, 2021, and 385 will vest on March 2, 2022. Each RSU represents the right to receive one ordinary share of Mylan N.V. One-third of the RSUs granted on March 2, 2018 vested on March 2, 2019 and the remainder of this award will vest equally on March 2, 2020 and March 2, 2021. Each RSU represents the right to receive one ordinary share of Mylan N.V. 831 of the RSUs granted on March 3, 2017 vested on March 3, 2018, 830 vested on March 3, 2019, and 830 will vest on March 3, 2020. Each RSU represents the right to receive one ordinary share of Mylan N.V. 220 of the RSUs granted on March 3, 2017 vested on March 3, 2018, 219 vested on March 3, 2019, and 220 will vest on March 3, 2020. The grant, of which these options were a part, vested in three equal annual installments beginning on March 5, 2010. Senior Vice President, Chief Accounting Officer & Corporate Controller /s/ Kevin Macikowski, by power of attorney 2019-03-05